Literature DB >> 20656364

PET scans in radiotherapy planning of lung cancer.

Dirk De Ruysscher1, Carl-Martin Kirsch.   

Abstract

Especially for non-small cell lung cancer, FDG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging. Copyright 2010 European Society for Therapeutic Radiology and Oncology and European Association of Nuclear Medicine. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20656364     DOI： 10.1016/j.radonc.2010.07.002

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  17 in total

1.  FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2).

Authors:  Pierre Vera; Sandrine Mezzani-Saillard; Agathe Edet-Sanson; Jean-François Ménard; Romain Modzelewski; Sebastien Thureau; Marc-Etienne Meyer; Khadija Jalali; Stéphane Bardet; Delphine Lerouge; Claire Houzard; Françoise Mornex; Pierre Olivier; Guillaume Faure; Caroline Rousseau; Marc-André Mahé; Philippe Gomez; Isabelle Brenot-Rossi; Naji Salem; Bernard Dubray
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

2.  Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.

Authors:  R A Bundschuh; N Andratschke; J Dinges; M N Duma; S T Astner; M Brügel; S I Ziegler; M Molls; M Schwaiger; M Essler
Journal:  Strahlenther Onkol       Date:  2012-03-24       Impact factor: 3.621

3.  Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.

Authors:  Judith van Loon; Claudia Offermann; Michel Ollers; Wouter van Elmpt; Erik Vegt; Ali Rahmy; Anne-Marie C Dingemans; Philippe Lambin; Dirk De Ruysscher
Journal:  Radiother Oncol       Date:  2011-05-14       Impact factor: 6.280

Review 4.  The use and misuse of positron emission tomography in lung cancer evaluation.

Authors:  Ching-Fei Chang; Afshin Rashtian; Michael K Gould
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

Review 5.  Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions.

Authors:  Carmen Vallejo Ocańa; Pilar Garrido López; Ignacio Muguruza Trueba
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

Review 6.  PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.

Authors:  Johan Bussink; Johannes H A M Kaanders; Winette T A van der Graaf; Wim J G Oyen
Journal:  Nat Rev Clin Oncol       Date:  2011-01-25       Impact factor: 66.675

7.  Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer.

Authors:  Wouter van Elmpt; Michel Ollers; Anne-Marie C Dingemans; Philippe Lambin; Dirk De Ruysscher
Journal:  J Nucl Med       Date:  2012-08-09       Impact factor: 10.057

8.  The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.

Authors:  Helen H W Chen; Bi-Fang Lee; Wu-Chou Su; Yu-Hsuan Lai; Hung-Yu Chen; How-Ran Guo; Wei-Jen Yao; Nan-Tsing Chiu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-07       Impact factor: 9.236

9.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

Authors:  P Veit-Haibach; D De Ruysscher; W van Elmpt; M Das; Martin Hüllner; H Sharifi; K Zegers; B Reymen; P Lambin; J E Wildberger; E G C Troost
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

10.  Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.

Authors:  Chunyan Duan; W Art Chaovalitwongse; Fangyun Bai; Daniel S Hippe; Shouyi Wang; Phawis Thammasorn; Larry A Pierce; Xiao Liu; Jianxin You; Robert S Miyaoka; Hubert J Vesselle; Paul E Kinahan; Ramesh Rengan; Jing Zeng; Stephen R Bowen
Journal:  Phys Med Biol       Date:  2020-10-07       Impact factor: 3.609
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.